Literature DB >> 21444613

Medication-based urolithiasis and atazanavir.

Paul M Koblic1, Wayne L Gold, Charles J L la Porte, Todd C Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21444613      PMCID： PMC3153546          DOI： 10.1503/cmaj.100019

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  12 in total

1.  Clinical toxicity of sulfonamides.

Authors:  D LEHR
Journal:  Ann N Y Acad Sci       Date:  1957-10-12       Impact factor: 5.691

Review 2.  Clinical practice. Acute renal colic from ureteral calculus.

Authors:  Joel M H Teichman
Journal:  N Engl J Med       Date:  2004-02-12       Impact factor: 91.245

3.  Atazanavir urolithiasis.

Authors:  Hernan R Chang; Pablo M Pella
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

4.  Type 2 diabetes increases the risk for uric acid stones.

Authors:  Michel Daudon; Olivier Traxer; Pierre Conort; Bernard Lacour; Paul Jungers
Journal:  J Am Soc Nephrol       Date:  2006-06-14       Impact factor: 10.121

Review 5.  Is prevention of stone recurrence financially worthwhile?

Authors:  W G Robertson
Journal:  Urol Res       Date:  2006-02-03

Review 6.  Kidney stones: pathophysiology and medical management.

Authors:  Orson W Moe
Journal:  Lancet       Date:  2006-01-28       Impact factor: 79.321

7.  Epidemiological trends in urolithiasis: impact on our health care systems.

Authors:  Alberto Trinchieri
Journal:  Urol Res       Date:  2006-01-27

8.  Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Authors:  Scott M Hammer; Joseph J Eron; Peter Reiss; Robert T Schooley; Melanie A Thompson; Sharon Walmsley; Pedro Cahn; Margaret A Fischl; Jose M Gatell; Martin S Hirsch; Donna M Jacobsen; Julio S G Montaner; Douglas D Richman; Patrick G Yeni; Paul A Volberding
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

Review 9.  Drug-induced renal calculi: epidemiology, prevention and management.

Authors:  Michel Daudon; Paul Jungers
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Atazanavir-associated nephrolithiasis: cases from the US Food and Drug Administration's Adverse Event Reporting System.

Authors:  Kirk M Chan-Tack; Melissa M Truffa; Kimberly A Struble; Debra B Birnkrant
Journal:  AIDS       Date:  2007-05-31       Impact factor: 4.177
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.